TNF inhibitors pose no important risk of lymphoma in patients with rheumatoid arthritis, the latest data from a large British registry confirms. Dr Louise Mercer and colleagues at the University of Manchester compared 11,931 patients with RA who had commenced a TNF inhibitor since 2001 and 3,367 who were treated with conventional DMARDs. The incidence ...
No lymphoma risk with anti-TNFs
10 Aug 2016